Clinical Trial Update: A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years [Phase 3]

View source ↗

Summary

Phase III trial evaluating the immunogenicity and safety of a lyophilized live-attenuated varicella vaccine in healthy subjects aged 13 to 55 years; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chickenpox
• Varicella

Drugs mentioned

• Lyophilized Live-Attenuated Varicella Vaccine (varicella vaccine, live attenuated)

Snippet

Sponsor: Southeast University, China | Conditions: Chickenpox Vaccines | Phase 3 | Status: COMPLETED